Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results

Provided By GlobeNewswire

Last update: Mar 27, 2025

Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)

Strategic alternatives process underway to maximize value creation across all assets in the company